Physician profile
Heather C Daniel
NPI 1811157878
$1,745.17
in general payments reported to CMS, 2019-2025
15 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $415 · 2022: $591 · 2023: $83.49 · 2024: $277 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $326.31 | 2021-2025 | Watchman Flx, Cds - Mct/Cem Monitoring, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $250.48 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $175.20 | 2024-2025 | Assure Wcd |
| Janssen Scientific Affairs, LLC | $124.99 | 2022 | |
| Esperion Therapeutics, INC. | $115.75 | 2021 | |
| Abiomed | $112.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $110.89 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $106.01 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.04 | 2021-2025 | Jardiance |
| Medtronic, INC. | $97.38 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.33 | 2023-2024 | Lifevest |
| Daiichi Sankyo INC. | $50.69 | 2025 | Enhertu |
| Janssen Pharmaceuticals, INC | $40.73 | 2022-2024 | Xarelto |
| Pfizer INC. | $20.67 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.